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Abstract
Background: Few smokers use effective smoking cessation aids (SCA) when trying to stop
smoking. Little is known why available SCA are used insufficiently. We therefore investigated the
reasons for not using SCA and examined related demographic, smoking behaviour, and
motivational variables.
Methods:  Data were collected in two population-based studies testing smoking cessation
interventions in north-eastern Germany. A total of 636 current smokers who had never used SCA
and had attempted to quit or reduce smoking within the last 12 months were given a questionnaire
to assess reasons for non-use. The questionnaire comprised two subscales: "Social and
environmental barriers" and "SCA unnecessary."
Results: The most endorsed reasons for non-use of SCA were the belief to be able to quit on
one's own (55.2%), the belief that help is not necessary (40.1%), and the belief that smoking does
not constitute a big problem in one's life (36.5%). One quarter of all smokers reported that smoking
cessation aids are not helpful in quitting and that the aids cost too much. Smokers intending to quit
agreed stronger to both subscales and smokers with lower education agreed stronger to the
subscale "Social and environmental barriers".
Conclusion: Main reasons for non-use of SCA are being overly self-confident and the perception
that SCA are not helpful. Future interventions to increase the use of SCA should address these
reasons in all smokers.
Background
Smoking is the most important single cause of morbidity
and mortality in industrialised countries [1]. Because
smoking prevention will not affect tobacco-related mor-
tality until the second half of the 21st century, quitting by
current smokers is the main way to achieve positive effects
on mortality in a medium term [2]. Many smokers are
interested in quitting. More than 70% of all smokers try to
quit smoking at least once in their lifetime [3]. In the
United States, 40% of all smokers reported that they had
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tried to quit within the last 12 months [4], and 70%
reported that they wanted to quit [5]. In Germany, lower
rates were found. Only 34% reported at least one quit
attempt within the last 12 months, and 43% said that they
wanted to quit [6].
To support smokers in their quit attempts, a wide range of
smoking cessation aids (SCA) is available. SCA comprise
methods and products to assist smokers in quitting
through coping with psychological or physical aspects of
nicotine dependence. Meta-analyses have shown that
smoking cessation courses, nicotine replacement therapy,
and bupropion can significantly increase success rates in
quitting [7]. Even minimal interventions such as self-help
materials have a small effect when compared with no
intervention [8]. In contrast to the evidence about the effi-
cacy of SCA, less than 23% of current smokers actually use
SCA when trying to quit smoking according to general
population studies in the US [9,10]. In Germany, 19%
have used SCA in at least one quit attempt during their
lifetime [11]. The question arises why smokers do not suf-
ficiently use available SCA. Therefore, we assessed reasons
for not using SCA in smokers who reported an unaided
quit or reduction attempt.
A limited number of studies investigating the utilisation
of SCA compared users and non-users. Those studies [10-
12] found that the use of SCA is more likely among
women, older persons, and persons with more than 12
years of education than among men, younger persons,
and persons with less than 12 years of education. Smok-
ing more cigarettes per day, having had more quit
attempts in the past, and a higher Fagerström Test for Nic-
otine Dependence score were positively associated with
SCA use. Furthermore, smokers utilising SCA are more fre-
quently allocated to stages with enhanced motivation to
stop smoking [11]. In the current study, we therefore
examined whether demographic, smoking behaviour, and
motivational variables predict the reasons for not using
SCA among smokers reporting an unaided quit or reduc-
tion attempt. It has been shown that smoking more ciga-
rettes per day, having a higher degree of nicotine
dependence, and less quit attempts in the past are associ-
ated with less success in quitting smoking [13]. Further-
more, the efficacy of nicotine replacement therapy has
been proven mainly for smokers smoking more than 10–
15 cigarettes per day [14]. Thus, smokers with an unfa-
vourable smoking behaviour (heavier smokers) are most
likely to benefit from the use of SCA. Therefore we further-
more investigated whether the reasons for non-use vary
between heavy and light smokers.
Methods
Study design
We used data from two smoking cessation intervention
studies conducted in Western Pomerania, a rural region in
north-eastern Germany. Both studies used a randomised
controlled design and for both studies ethical approval
has been obtained from the ethics committee of the phy-
sician chamber of Mecklenburg-Vorpommern at the Uni-
versity of Greifswald, Germany. One of these studies was
conducted with a general population sample, the other
one was conducted in general medical practices which in
Germany also provide access to the general population.
General population data revealed that more than 80% of
the general population consult a physician at least once a
year [15]. Both studies were designed to evaluate the effec-
tiveness of brief motivational interventions. The interven-
tions were based on the Transtheoretical Model of
Behaviour Change [16]. This model provides a framework
for describing, explaining, and influencing health behav-
iours such as tobacco smoking. Core elements are the five
stages of change, three within current smokers to describe
different levels of readiness to quit smoking and two
within former smokers to distinguish short-term and
long-term quitters, 10 processes of change, which refer to
activities that people use to progress through the stages of
change, decisional balance (the pros and cons of changing
a behaviour), and self-efficacy (conceptualised as situa-
tion-specific confidence to refrain from smoking). This
framework is used to tailor interventions to the individual
needs of each smoker. The interventions were delivered in
form of either individualised letters or personal counsel-
ling. Information about SCA was given to persons who
planned to quit smoking within the next four weeks. The
provision of medication or formal behavioural interven-
tions was not part of the study protocol. In both studies, a
baseline assessment and up to four follow-up assessments
were carried out. All measures reported in the current
paper were assessed in the baseline and the 6-month fol-
low-up questionnaires and were identical in the popula-
tion-based and the general practice study.
Samples
Population-based sample
Subjects identified as current smokers in a general popu-
lation health examination survey, the "Study of Health in
Pomerania" [SHIP;[17]], were eligible as participants of
the smoking intervention study. Inclusion criteria were
(1) answering "Yes" to at least one of the following ques-
tions "Do you currently smoke cigarettes?", "Do you cur-
rently smoke cigars or cigarillos", "Are you currently a
pipe smoker?" (2) being between 20 and 79 years and (3)
providing written informed consent to participate in the
study. Of 1,315 persons identified as smokers, 917
(69.7%) completed the baseline assessment, which was
conducted from April 2002 to November 2002. The 6-BMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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month follow-up was completed by 760 persons (82.9%)
[18]. Compared to non-responders participants had a
higher educational level (OR = 1.894, CI: 1.279–2.805;
OR = 1.572, CI: .945–2.614), but did not differ with
regard to all other demographic and smoking behaviour
variables described below. Both baseline and 6-month
follow-up assessment were paper-pencil questionnaires
mailed to the participant's home.
General practice patient sample
To yield a representative sample of patients attending the
primary medical care system in the same region as the
population-based study, a two-step sampling procedure
was applied [19]. In the first step, a random sample was
drawn from all practitioners registered for primary medi-
cal care in the given region. A total of 34, out of 39, prac-
titioners took part in the study (participation rate 87.2%).
In the second step, all consecutive patients visiting the
practices were screened for smoking status by a research
nurse for a period of three weeks. This recruitment phase
lasted from April 2002 to September 2003. Of 2,016 iden-
tified smokers aged 18 to 70 years, 1,653 (82.0%) gave
written informed consent to participate and 1,610
(79.9%) completed the baseline questionnaire, which
was administered in the waiting room. At the 6-month
follow-up, 1,234 patients (76.6%) were re-assessed via
computer-assisted telephone interview or via paper-pencil
questionnaire when a participant could not be reached by
phone. Persons who completed the 6-month follow-up
were older (OR = 1.025, CI: 1.015–1.034) and had a
higher educational level (OR = 1.639, CI: 1.268–2.120;
OR = 2.315, CI: 1.566–3.422) than non-responders. No
differences have been found with respect to all other
demographic and smoking behaviour variables described
below.
Sample for analysis
The interventions were not designed to directly support
the utilisation of SCA, thus we included participants allo-
cated to the intervention as well as to the control condi-
tion. Taken both studies together, 1,994 participants
completed the 6-month follow-up assessment. Of those,
smokers smoking exclusively cigars, cigarillos or pipe,
occasional smokers and smokers who stopped smoking
during the study were excluded. The remaining 1,632 cur-
rent daily cigarette smokers were asked: "Have you ever
used one of the following SCA: nicotine replacement
products (patch, spray, gum), bupropion, self-help mate-
rials (book, brochure, CD, videotape), smoking cessation
courses, acupuncture or hypnosis treatment?". We
included acupuncture and hypnosis, although effective-
ness of these SCA has not been proven. However, it has
been reported that they are used as often as other SCA
[11,12]. Smokers stating never to have used any of those
SCA were further asked to answer a questionnaire about
the reasons for non-use of SCA in the past. Asking smok-
ers why they have not utilised SCA requires that they have
had an opportunity to use SCA. Therefore, only those 636
smokers additionally reporting at least one serious
attempt to quit or to substantially reduce smoking in the
past 12 months were included in the present analysis.
Measurements/Assessments
A series of demographic, smoking behaviour, motiva-
tional, and health-related variables assessed at baseline
was used as potential predictors of the reasons for not
using SCA. Demographic measures included gender, age,
marital status, and education, representing the three most
common educational levels in Germany (<10, 10, >10
years at school). Smoking variables included cigarettes per
day, age at onset of smoking (<16, 16–18, >18 years),
number of quit attempts (0, 1, 2–5, >5) within the last 12
months and the Fagerström Test for Nicotine Dependence
[FTND; [20]]. Smoking intensity was assessed using a Ger-
man translation of the phrase: "Please indicate on a scale
between 0 and 100 the intensity of your smoking.", with
0 being "not intensive at all" and 100 being "very inten-
sive" [21]. We differentiated smokers not intending to
quit within the next six months and smokers intending to
quit within the next six months. Self-efficacy of behaviour
change [22] was assessed using an instrument that asks
subjects to indicate their confidence to refrain from smok-
ing across nine tempting situations on a five-point Likert
scale. Higher scores indicated stronger confidence. For
assessment of the pros of non-smoking [22], the smokers
indicated the importance of five statements about positive
aspects of non-smoking on a five-point Likert scale.
Higher scores indicated greater importance. General
health was assessed with the EuroQol visual analogue
scale [EQ-VAS; [23]], a self-rating scale ranging from 0
(worst imaginable health state) to 100 (best imaginable
health state). We used a German version of the Five-Item
Mental Health Inventory Screening Test [MHI; [24]] to
assess affective mental health. In this version subjects
indicated on a five-point rating scale (ranging from 1
"none of the time" to 5 "all of the time") the frequency of
the occurrence of two anxiety-related and three mood dis-
order-related symptoms during the last month [25].
Higher sum scores indicated a more favourable mental
health.
Questionnaire for not using SCA
At 6-month follow-up, a questionnaire was used to assess
the reasons for not using SCA in persons who had never
used any SCA and additionally reported an attempt to
quit or reduce smoking within the last 12 months. The
questionnaire was adapted from previous research on
alcohol dependence and misuse [26,27]. We selected 10
items and modified them to refer to tobacco smoking.
Four additional items were created to assess reasons forBMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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non-use of aids specifically for the field of tobacco smok-
ing (Table 1). Subjects were asked to indicate their agree-
ment on a five-point rating scale from 1 "not at all
applicable" to 5 "very applicable". Exploratory factor anal-
yses with oblique rotation revealed two factors that could
be interpreted as the subscales "Social and environmental
barriers" and "SCA unnecessary". Internal consistencies of
the two scales were α = .80 and α = .57, respectively. Factor
loadings ranged from .355 to .795 for subscale "Social and
environmental barriers" and .250 to .539 for subscale
"SCA unnecessary" (Table 1).
Statistical analyses
All data analyses were conducted using SPSS 12.0 and
STATA 9.0. Descriptive statistics were used to indicate the
most important reasons for not using SCA. Percentage of
endorsement of a reason for not using SCA was computed
combining the two highest rating categories (rating 4 and
5), rejection was computed combining the two lowest rat-
ing categories (rating 1 and 2). Regression analyses were
performed to predict the reasons for non-use of SCA. The
two subscales "Social and environmental barriers" and
"SCA unnecessary" were used as dependent variables. For
both subscales, a mean score across all items was com-
puted. Baseline assessments of demographic, smoking
behaviour, motivational, and health-related variables
were used as predictors. For rating scales (MHI, pros of
non-smoking, self-efficacy) mean scores across all items
(ranging from 1 to 5) were computed. Because data were
collected as part of two smoking cessation intervention
studies, preliminary analyses were conducted to ensure
that the results were not biased by study membership
(population-based vs. general practice patient sample)
and study group membership (intervention vs. control
condition). The scale "SCA unnecessary" differed signifi-
cantly between the two studies (p < .05). Furthermore the
use of SCA was significantly higher in the intervention
than in the control condition (p = .001), thus we adjusted
for study membership as well as study group membership
in all regression analyses. In a first step, bivariate regres-
sion analyses were performed to identify possible predic-
tors. In a second step, all univariate significant variables (p
< .05) were included in a multivariable model. Because
the scale "Social and environmental barriers" was highly
skewed we dichotomised this scale using 1 as cut-off. One
group consisted of persons who did not agree to any of the
items (coded 0) and the other group consisted of persons
who agreed to at least one of the items (coded 1). Thus for
this scale logistic regression analyses were performed,
whereas for the scale "SCA unnecessary" linear regressions
were used. We defined smokers smoking at least 15 ciga-
rettes per day as heavy smokers and smokers smoking less
than 15 cigarettes per day as light smokers. Chi-square sta-
tistics were used to compare the percentage of endorse-
ment of the reasons between heavy and light smokers. To
examine predictors of the reasons for non-use in heavy
smokers we reran the regression analyses excluding smok-
ers smoking less than 15 cigarettes per day.
Table 1: Reasons for not using smoking cessation aids. Factor loadings, frequency distributions and means (SD) for individual items.
Factor loading Not at all 
applicable
Very
applicable
Factor 1 Factor 2 1
(%)
2
(%)
3
(%)
4
(%)
5
(%)
M (SD)
Scale "Social and environmental barriers" 1.85 (0.83)
I did not know where to turn to in order to use the aids. .408 .127 63.5 7.1 10.2 4.9 11.0 1.89 (1.41)
I was worried what other people would think about me. .680 -.132 76.9 7.2 7.5 1.6 3.3 1.42 (0.95)
I thought it would take too much time and energy to use the 
aids.
.525 .062 54.6 11.3 15.6 6.1 9.0 2.00 (1.35)
I did not want to admit to myself that I needed the aids. .355 .298 44.8 10.1 17.5 8.8 15.1 2.37 (1.51)
I was too proud to use the aids. .650 .051 67.8 7.9 9.0 4.2 7.4 1.71 (1.26)
It was unpleasant or embarrassing to use the aids. .795 -.086 72.3 6.4 7.5 3.9 6.0 1.59 (1.18)
I did not feel able to talk to others about my smoking. .698 -.111 71.1 7.1 7.9 3.8 6.4 1.62 (1.20)
I thought the aids would cost too much. .389 .222 51.9 8.8 11.8 7.1 16.5 2.25 (1.57)
I did not know that such aids existed. .414 .096 66.2 6.4 7.1 3.5 12.1 1.83 (1.42)
Scale "SCA unnecessary" 2.92 (0.91)
I believed that the aids would not help me with my attempt to 
give up or reduce smoking.
.169 .371 37.3 11.2 23.4 8.8 15.7 2.53 (1.48)
I thought I would be able to quit or reduce smoking on my own. -139 .518 17.9 7.9 15.7 16.0 39.2 3.52 (1.53)
I had the feeling that smoking did not constitute a big problem in 
my life.
.076 .250 21.9 11.0 26.9 16.7 19.8 3.02 (1.60)
I thought that I did not need these aids. -.021 .539 29.7 7.9 18.9 13.2 26.9 3.00 (1.42)
I believed that nothing would help me in my attempt to give up 
or reduce smoking.
.199 .460 34.0 12.3 25.5 9.6 14.0 2.55 (1.43)BMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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Results
Among the 1,632 daily cigarette smokers, 361 (22.1%)
had ever used SCA. Among the remaining 1,238 never-
users (33 smokers did not provide any information about
SCA use), 636 (51.4%) reported a quit or reduction
attempt within the last 12 months and were therefore eli-
gible for the present analyses. Those 636 participants were
on average 38.25 (SD = 14.92) years old, 53.1% were
male. Most of them (66.2%) had at least 10 years of
school education and 72.5% were married or lived in a
stable partnership. The number of cigarettes smoked per
day ranged from 1 to 45 (mean 14.99; SD = 7.17), the
mean FTND score was 2.84 (SD = 1.98) and 62.4%
intended to quit within the next six months.
The most frequently endorsed reasons for not using SCA
were "I thought I would be able to quit or reduce smoking
on my own" (55.2%), "I thought that I did not need these
aids" (40.1%) and "I had the feeling that smoking did not
constitute a big problem in my life" (36.5%). One quarter
agreed that SCA would not help them to stop or reduce
smoking, that nothing would help in trying to stop or
reduce smoking, that SCA would cost too much, and that
they did not want to admit to themselves that they needed
these aids (Table 1). The most frequently opposed reasons
were "I was worried what other people would think about
me" (84.1%), "It was unpleasant or embarrassing to use
the aids" (78.7%) and "I did not feel able to talk to others
about my smoking" (78.2%).
Univariate logistic regression analyses showed that men,
smokers with less than 10 years of school education,
smokers smoking more cigarettes per day, smokers with a
higher FTND score, smokers smoking more intensive, and
smokers intending to quit within the next six months had
a higher agreement to the scale "Social and environmental
barriers" (Table 2). The multivariable model including
these variables revealed that a higher educational level
decreased the odds while intention to quit within the next
six months increased the odds for agreement to the scale.
Linear regressions were performed to identify variables
associated with the scale "SCA unnecessary". Intention to
quit smoking within the next six months, and a worse
mental health increased the agreement to this scale (Table
2). When both variables were entered simultaneously in a
multivariable regression model, only intention to quit
smoking remained significant.
Compared with light smokers (less than 15 cigarettes per
day), a significantly higher percentage of heavy smokers
(at least 15 cigarettes per day) endorsed the following rea-
sons (Table 3): not wanting to admit to oneself to be in
need of SCA, concerns that SCA would cost too much or
would be unpleasant or embarrassing to use, the belief
that nothing would help in the attempt to quit or reduce
and that the use of SCA would take too much time and
energy. Regression analyses in heavy smokers showed that
smokers with more than 10 years of school education
showed less agreement to the scale "Social and environ-
mental barriers" than smokers with less than 10 years of
school education (OR = .464, CI: .201–1.072; OR = .146,
CI: .053–.397). Intending to quit smoking within the next
six months was related to a stronger agreement to the scale
"SCA unnecessary" in heavy smokers (β = .114, p = .042).
Discussion
The main finding is that the reasons for not using SCA can
be seen in attitudes and beliefs of the smokers towards
smoking cessation and SCA rather than in social and envi-
ronmental barriers. Smokers who do not use SCA think to
be able to quit or reduce smoking on their own. They do
not perceive smoking as a problem and therefore do not
believe to need help. That heavy and light smokers do not
differ in their agreement to these reasons reflects a high
confidence of both groups in their ability to quit without
help but may also reflect an underestimation of the prob-
lems associated with smoking cessation particularly in
heavy smokers. Furthermore smokers do not think that
SCA are helpful. There seems to be a discrepancy between
the scientifically proven effectiveness of SCA [7,8] and the
individually perceived effectiveness in persons most in
need of these aids, i.e., the smokers who failed in previous
quit attempts. This is corroborated by a study showing
that only 20% of smokers are convinced that SCA increase
their chances in quitting [28]. In addition to these rea-
sons, one important environmental barrier could be
found. For a quarter of all smokers, the costs of SCA are a
reason for non-use. The costs for e.g. nicotine replacement
therapy are calculated not to extend the costs for an equiv-
alent amount of cigarettes smoked before. But smokers
may consider only the additional costs for SCA compared
with no costs for quitting on one's own.
Although the most important reasons for non-use are the
same in heavy and light smokers, there are differences
between these groups. The expected costs as well as the
belief that nothing would help in the attempt to quit or
reduce are more relevant for heavy smokers. Furthermore
the (social) aspects that using SCA means admitting to
need help and the fear of embarrassment deter heavy
smokers more strongly from SCA use than light smokers.
So the belief that smoking cessation is something which
has to be done on one's own seems to be more important
for heavy smokers. This has to be kept in mind particu-
larly when planning interventions for heavy smokers.
In interpreting these findings, the climate according to
tobacco prevention and control must be taken into
account. Germany is a country with low anti-smoking cli-
mate [29] and relatively high smoking prevalence, and theBMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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pressure to quit smoking is small. Smoking is widely
accepted in the German society, which is reflected in a
lower number of quit attempts and a lower motivation to
quit than in the US [4,5] or other European countries
[6,29]. Thus, fewer smokers have the experience of with-
drawal symptoms and other problems impeding smoking
cessation. Furthermore, in contrast to other countries such
as the UK [30] and partly the US [31], in Germany costs
for nicotine replacement therapy and bupropion are not
covered by health insurance. Smoking cessation courses
also require co-payments. This might explain why costs of
SCA are given as a reason for non-use. It might also reflect
that nicotine dependence is not sufficiently accepted by
society as a disease for which free help should be offered.
Our finding that 25 % do not use SCA because they do not
want to admit needing help to themselves might reflect
this feeling that smoking cessation should be done on
one's own. These specific circumstances in Germany may
Table 2: Logistica and linearb regression to predict reasons for not using smoking cessation aids from demographic, smoking behaviour, 
motivational, and health-related variables
Prediction variables Scale "Social and environmental barriers"
OR (CI 95%)
Scale "SCA unnecessary"
β-weight
univariate multivariable univariate multivariable
demographic variables
gender
malec
female .559 (.371–.843) .620 (.376–1.020) -.019 -d
age 1.004 (.989–1.019) - -.065 -
educational level
< 10 yearsc
= 10 years .382 (.219–.668) .500 (.267–.936) -.013
> 10 years .220 (.111–.434) .297 (.139–.632) -.012 -
marital status
married/living with a partnerc
not married/not living with a partner .783 (.486–1.262) - -.019 -
smoking behaviour variables
cigarettes per day 1.048 (1.015–1.082) 1.015 (.969–1.063) .071 -
FTND-Scoree 1.274 (1.098–1.477) 1.206 (.992–1.466) .041 -
age at onset
< 16 yearsc
16–18 years 1.219 (.758–1.959) .012
> 18 years 1.091 (.613–1.942) - -.070 -
quit attempts within the last 12 months
0c
1 1.379 (.780–2.438) .011
2–5 1.528 (.852–2.742) .057
>5 1.051 (.389–2.839) - .016 -
smoking intensity 1.012 (1.003–1.021) 1.001 (.990–1.013) .076 -
motivational variables
intention to quit within the next six months
noc
yes 1.583 (1.013–2.473) 2.008 (1.207–3.338) .121** .113**
pros of non-smoking 1.148 (.957–1.376) - .078 -
self-efficacy .885 (.696–1.125) - .063 -
health-related variables
mental health .927 (.684–1.257) - -.083* -.073
general health .989 (.976–1.001) - .022 -
All analyses were adjusted for study membership (population-based vs. general practice patient sample) as well as study group membership 
(intervention vs. control condition).
a Scale „Social and environmental barriers", due to substantial non-normality the scale was dichotomised using 0 = no agreement, 1 = at least 
minimal agreement
b Scale "SCA unnecessary"
c Reference category
d Not sufficient for multivariable analysis
e Because cigarettes per day were used as separate predictor, the FTND score was computed without cigarettes per day to avoid multi-collinearity
* p < .05; ** p < .01BMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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compromise the generalisability of our findings across
countries, because different smoking climates may influ-
ence the reasons for not using SCA.
Our findings suggest that interventions and campaigns
aiming to increase the use of SCA, particularly in heavy
smokers, and thus increase the number of successful quit
attempts should address the following issues: First, if
smokers are provided with fewer opportunities to smoke,
the smokers' perception of their competences to quit
smoking on their own might be adjusted. In this regard,
smoking bans in public buildings or workplaces can be
helpful. Second, higher perceived effectiveness of SCA is
associated with more frequent use [28,32]. Public educa-
tion campaigns should address this issue. One aspect in
such campaigns might be that smokers as well as health
care providers should be aware that SCA are no stand-
alone solution. SCA assist in smoking cessation but
require motivation to quit and behavioural efforts as pre-
requisites. Heavy smokers in particular refrain from using
SCA because of the perceived ineffectiveness. This makes
it even more important to clarify that the available SCA
are effective in particular for heavy smokers. Third, costs
are a barrier of SCA use. Studies have shown financial cov-
erage of SCA to be associated with increased use, quit
attempts, and successful quitting [33-35]. This implies
that reducing the costs of SCA might have a positive effect
on the use of SCA.
We found that smokers intending to quit smoking within
the next six months showed stronger agreement to both
subscales ("Social and environmental barriers" and "SCA
unnecessary") than smokers not intending to quit. One
interpretation might be that this reflects greater cognitive
involvement of smokers who are further along in the ces-
sation process. Those smokers have already made up their
mind and decided not to use any kind of help. Therefore,
their reasons for not using SCA are more elaborated. These
Table 3: Endorsement of reasons for not using smoking cessation aids for heavy (at least 15 cigarettes per day) and light (less than 15 
cigarettes per day) smokers.
heavy smokers (>= 15 CPD) endorsement light smokers (<15 CPD) endorsement χ2-statistics
yes
% (N)
no
% (N)
yes
% (N)
no
% (N)
χ2-value (df) p-value
Scale "Social and environmental 
barriers"
I did not know where to turn to 
in order to use the aids.
17.9 (28) 82.1 (267) 14.1 (38) 85.9 (232) 1.55 (1) .213
I was worried what other people 
would think about me.
5.9 (19) 94.1 (305) 4.4 (12) 95.6 (258) 0.60 (1) .439
I thought it would take too much 
time and energy to use the aids.
18.2 (59) 81.8 (266) 12.3 (33) 87.7 (236) 3.90 (1) .048
I did not want to admit to myself 
that I needed the aids.
29.6 (96) 70.4 (228) 18.7 (50) 81.3 (218) 9.51 (1) .002
I was too proud to use the aids. 12.0 (39) 88.0 (286) 11.2 (30) 88.8 (237) 0.08 (1) .773
It was unpleasant or 
embarrassing to use the aids.
12.9 (42) 87.1 (283) 6.7 (18) 93.3 (249) 6.15 (1) .013
I did not feel able to talk to 
others about my smoking.
11.4 (37) 88.6 (288) 9.0 (24) 91.0 (243) 0.91 (1) .340
I thought the aids would cost too 
much.
28.8 (94) 71.2 (232) 18.1 (48) 81.9 (217) 9.20 (1) .002
I did not know that such aids 
existed.
18.3 (59) 81.7 (264) 12.9 (34) 87.1 (229) 3.09 (1) .079
Scale "SCA unnecessary"
I believed that the aids would not 
help me with my attempt to give 
up or reduce smoking.
27.1 (88) 72.9 (237) 23.5 (63) 76.5 (205) 0.97 (1) .321
I thought I would be able to quit 
or reduce smoking on my own.
57.5 (187) 42.5 (138) 55.9 (151) 44.1 (119) 0.16 (1) .693
I had the feeling that smoking did 
not constitute a big problem in 
my life.
39.9 (129) 60.1 (194) 34.6 (93) 65.4 (176) 1.80 (1) .179
I thought that I did not need 
these aids.
40.7 (133) 59.3 (194) 41.2 (110) 58.8 (157) 0.02 (1) .897
I believed that nothing would 
help me in my attempt to give up 
or reduce smoking.
27.9 (90) 72.1 (233) 20.2 (53) 79.8 (210) 4.67 (1) .031BMC Public Health 2008, 8:129 http://www.biomedcentral.com/1471-2458/8/129
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results highlight the necessity to address SCA already in
smokers who are not motivated to quit, before they have
consolidated how they want to quit. This is in line with
other studies which confirm that SCA should be offered to
all smokers irrespective of their motivation to quit
[36,37]. In heavy smokers the intention to quit was only
related to the subscale "SCA unnecessary". This suggests
that in heavy smokers not intending to quit the offer of
SCA should be accompanied by a brief counselling to
emphasise that smoking more cigarettes per day hampers
smoking cessation [13] and that thus especially heavy
smokers can profit from SCA such as nicotine replacement
therapy [14]. Social and environmental barriers seem to
be especially important for people with a lower educa-
tional level. This finding also stays significant when
focussing exclusively on heavy smokers. Knowing that the
use of SCA is more likely among people with higher edu-
cation [12], additionally focussing on social aspects (e.g.
talking to others) or environmental barriers (e.g. provid-
ing information about costs and places to turn to in order
to get help) might be promising to increase the use of SCA
in heavy smokers with lower education.
Our study has some limitations: (1) We assessed the rea-
sons for non-use retrospectively in participants who
unsuccessfully attempted to quit or reduce smoking. Thus
cognitive processing resulting from the failure of the quit
or reduction attempt and limited recall might have influ-
enced our results. For example, participants who
attempted and failed to quit might be likely to retrospec-
tively report that SCA were unnecessary. Future studies
should therefore assess reasons for non-use close to a
given quit attempt, before the success or failure is obvious.
(2) Our rationale was to focus on smokers reporting a quit
or reduction attempt within the last 12 months. This con-
straint is founded in the wording of the questionnaire.
Asking smokers why they have not utilised any SCA when
trying to stop or reduce smoking assumes that they have
had at least one opportunity to use any. Furthermore,
assessing reasons related to an actual behaviour may be
able to obtain more elaborated cognition. However, this
means that our sample excluded smokers without a quit
or reduction attempt. Therefore we were not able to inves-
tigate if and how general attitudes towards SCA influence
whether a smoker tries to quit or reduce smoking. Future
studies should therefore investigate whether those atti-
tudes influence subsequent quit attempts. (3) We assessed
reasons for non-use across a combination of all kinds of
SCA. Reasons for non-use may differ between different
kinds of SCA. For example, expenditure of time and
money may vary between different SCA, which in turn
may influence perceived reasons for non-use. In our
study, we decided to assess the reasons for non-use glo-
bally for all kinds of SCA combined but not for single
SCA, because in Germany information about SCA and the
public awareness of the different kinds of SCA are low.
Only 19% of current smokers have ever used SCA, with
2.8% reporting use of multiple SCA [11]. Thus differenti-
ating reasons for non-use between SCA was not appropri-
ate. (4) We adapted a questionnaire from alcohol
dependence and misuse research to smoking cessation
research. Although we added four smoking specific items,
the reasons for non-use in the field of tobacco smoking
might not have been covered completely. Psychometric
development of a questionnaire with specific tobacco
items is clearly desirable, but remains a task for future
research. (5) Generalisation of our findings might be lim-
ited because our sample consisted of persons from two
smoking cessation studies in Western Pomerania. How-
ever, both studies used population recruitment
approaches, which assure the inclusion of a wide variety
of smoking patterns, e.g. smokers not intending to quit
within the next months. Because attrition was associated
with educational level (population-based sample) and
age as well as educational level (general practice patient
sample), our findings might not apply to younger persons
with a low educational level.
Conclusion
Our findings suggest that the main reasons for non-use of
SCA are being overly self-confident and the perception
that SCA are not helpful. These reasons are modifiable in
nature and thus indicate potential targets for future inter-
ventions to increase the use of SCA.
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